Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

ABSTRACTChanges in the immune system induced by tyrosine kinase inhibitors (TKI) have been shown to positively correlate with therapy responses in chronic myeloid leukemia (CML). However, only a fe...